A vaccine for respiratory syncytial virus (RSV) is now available for older Canadians, but experts worry that cost of the vaccine could be a barrier to seniors and could lead to preventable hospitalizations — and potentially, death.
Health
Cost of RSV vaccine a barrier to older Canadians amid respiratory season, experts warn
More Videos
-
Invasive meningococcal disease cases spiking in Manitoba, Ontario
-
Why switching to a plant-based diet could pose a risk for your heart
-
Health Matters: Study finds 5% of animal-tested therapies reach humans
-
Dengue fever is rising in Europe — What should Canadian travellers know?
-
Health Matters: 424 Ontario patients forced into long-term care homes they didn’t choose
-
Infectious disease physicians issue bird flu guidance for Canada
You are viewing an Accelerated Mobile Webpage.
View Original Article